Sort   by:  
 Page size 
UnknownSoluble HLA-G expression levels and HLA-G/irinotecan association in metastatic colorectal cancer treated with irinotecan-based strategy.
Not available
S-EPMC7260212 | biostudies-literature
UnknownHypoxic Modulation of HLA-G Expression through the Metabolic Sensor HIF-1 in Human Cancer Cells.
Not available
S-EPMC5525073 | biostudies-literature
UnknownAssociation of HLA-G 3'UTR Polymorphisms with Response to First-Line FOLFIRI Treatment in Metastatic Colorectal Cancer.
Not available
S-EPMC9788252 | biostudies-literature
UnknownHLA-G 3'UTR Polymorphisms Impact the Prognosis of Stage II-III CRC Patients in Fluoropyrimidine-Based Treatment.
Not available
S-EPMC4669157 | biostudies-literature
UnknownHLA-G 3'UTR Polymorphisms Predict Drug-Induced G3-4 Toxicity Related to Folinic Acid/5-Fluorouracil/Oxaliplatin (FOLFOX4) Chemotherapy in Non-Metastatic Colorectal Cancer.
Not available
S-EPMC5535859 | biostudies-literature
UnknownThe Conformational Dynamics of the Ligands Determines the Electronic Circular Dichroism of the Chiral Au38(SC2H4Ph)24 Cluster.
Not available
S-EPMC9940292 | biostudies-literature
UnknownGut Microbiota-Based Immunotherapy: Engineered <i>Escherichia coli</i> Nissle 1917 for Oral Delivery of Glypican-1 in Pancreatic Cancer.
Not available
S-EPMC12028767 | biostudies-literature
UnknownCisplatin resistance can be curtailed by blunting Bnip3-mediated mitochondrial autophagy.
Not available
S-EPMC9033831 | biostudies-literature
UnknownImproved Progression-Free Survival in Irinotecan-Treated Metastatic Colorectal Cancer Patients Carrying the HNF1A Coding Variant p.I27L.
Not available
S-EPMC5641335 | biostudies-literature
UnknownCandidate germline polymorphisms of genes belonging to the pathways of four drugs used in osteosarcoma standard chemotherapy associated with risk, survival and toxicity in non-metastatic high-grade osteosarcoma.
Not available
S-EPMC5308704 | biostudies-literature
Sort   by:  
 Page size